Recruiting

Improved MRI Contrast for Enhanced Brain Morphology and Activity Characterization

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study aims to develop and evaluate new MRI techniques for a clearer view of brain structure and activity at different field strengths, with the primary outcome being the ability to robustly acquire detailed whole brain images sensitive to various factors such as myelin, iron, and blood flow.

What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

From 18 to 120 Years
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: July 2000
See protocol details

Summary

Principal SponsorNational Institute of Neurological Disorders and Stroke (NINDS)
Study ContactJeffrey H Duyn, Ph.D.More contacts
Last updated: October 8, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: July 1, 2000

Actual date on which the first participant was enrolled.

Objective The goal of this protocol is to improve spatial resolution and contrast in MRI studies of brain anatomy and function, by developing novel hardware, and image acquisition and reconstruction techniques. Specifically, by improving MRI image quality and manipulating MRI contrast, we aim to better characterize and quantify structural, chemical, and blood flow variations across the brain, and study their relationship with neuronal activity. For this purpose, we will develop and optimize novel MRI techniques on normal, healthy volunteers, and combine these with EEG and recording of other physiological signals. Study Population Any healthy, male or female volunteer 18 years of age and older; the subjects must be capable of understanding the procedures and requirements of this study and be willing to sign an informed consent document. Design This is a technical development study design to develop and evaluate new MR technology for performing MRI and functional MRI in the CNS with novel contrasts and with a high spatial resolution. Outcome Measures The primary outcome of this study will be the ability to acquire anatomical and functional images of the human brain with high spatial resolution, i.e., 200-500 micron and 750-1000 micron respectively. In addition, developed techniques will allow the robust measurement of specific tissue properties, including diffusion, structural anisotropy, iron and myelin content, perfusion, and metabolite concentrations. The relative merits of blood flow and blood oxygenation level dependent (BOLD) functional MRI (fMRI) techniques, and their particular spatial and temporal signal characteristics will be established. It will be determined whether information valuable to interpret BOLD fMRI can be derived from EEG and other physiological signals.

NCT00004577
Principal SponsorNational Institute of Neurological Disorders and Stroke (NINDS)
Study ContactJeffrey H Duyn, Ph.D.More contacts
Last updated: October 8, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

1100 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 120 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

* INCLUSION CRITERIA: * 18 years of age and older * in good general health * able to understand the procedures and requirements and give informed consent EXCLUSION CRITERIA: All Subjects will undergo a neurological physical and answer the Healthy volunteer form, and the most-recent version of the NMR safety screening form A subject will be excluded if he/she: 1. has any metal implant or objects of unknown identity or composition, or if it s known to be non-compatible with MRI, such as pacemakers, medication pumps, aneurysm clips, metallic prosthesis (such as heart valves or cochlear implants), certain orthopedic implants (pins and rods), shrapnel, or small metal fragments in the eye; 2. has claustrophobia; 3. cannot lie comfortably for up to 120 minutes; 4. underwent brain surgery or suffered a traumatic head trauma; 5. has migraines that require medication; 6. has ever been hospitalized for a psychiatric disorder; 7. has medical health problems such as pulmonary or airway disease, heart failure, coronary artery disease, and uncontrolled hypertension which would require physiological monitoring during the scan; 8. has a history of any medical condition that could result in an emergency medical situation while undergoing the MRI scan; 9. has hearing problems which would make it difficult to tolerate scanner noise; 10. is pregnant; 11. has body/make-up tattoos (e.g. lips, eyebrows, eyeliner). Each tattoo will be considered on a case-to-case basis, taking into account of the age and location of the tattoo; 12. has a sleep apnea diagnosis; 13. has a neurological disorder, such as Stroke, Parkinson s, and Epilepsy; 14. a member of the NINDS Laboratory of Functional and Molecular Imaging. The contraindications to MRI at the various field strengths are almost identical, except the 7 T also excludes subjects with gold dental crowns.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

National Institutes of Health Clinical Center

Bethesda, United StatesOpen National Institutes of Health Clinical Center in Google Maps
Recruiting
One Study Center